GENE ONLINE|News &
Opinion
Blog

Chugai Pharmaceutical
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Building Bridges at the Brand-New Chugai Life Science Park
2023-10-10
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
FDA
Weekly Cover:Foundation Medicine and Chugai Partnership with National Cancer Center
2020-02-18
Weekly Cover: Expansion of Samsung Biologics Projects into U.S. and Europe
2020-02-11
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Weekly in Asia|Nov-3
2019-12-03
Weekly in Asia|Nov
2019-11-07
Weekly in Asia(0407-0413)
2019-04-19
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
EVENT
Scroll to Top